PBS listing for first pan-genotypic antiviral hep C treatment

Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, Health Minister Greg Hunt said today, World Hepatitis Day (July 28). Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) is a pan-genotypic regimen for the treatment of